ACRS - Aclaris Therapeutics, Inc.
3.52
0 0%
Share volume: 2,387,986
Last Updated: 03-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$3.52
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-07-2024 | 11-06-2024 | 02-27-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 02-26-2026 | |
| Cash flow financing | -55.000 K | -11.000 K | 22.000 K | 74.580 M | -275.000 K | -9.000 K | -3.044 M | -2.534 M | |
| Other financing cash flows | -55.000 K | -11.000 K | 22.000 K | 74.580 M | -275.000 K | -9.000 K | -3.044 M | -2.534 M | |
| Cash flow | -4.037 M | -13.007 M | 24.817 M | -23.081 M | 5.787 M | -4.955 M | -146.000 K | -5.296 M | |
| Net income | -16.941 M | -10.986 M | -7.586 M | -96.552 M | -15.085 M | -15.429 M | -14.614 M | -19.795 M | |
| Depreciation | 243.000 K | 242.000 K | 179.000 K | 143.000 K | 128.000 K | 114.000 K | 110.000 K | 102.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 16.833 M | -674.000 K | 2.795 M | -88.723 M | 19.119 M | 5.047 M | 13.830 M | 10.369 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 135.000 K | -14.000 K | 0.000 | 0.000 | 43.000 K | 21.000 K | 23.000 K | 24.000 K | |
| Cash Change | -4.037 M | -13.007 M | 24.817 M | -23.081 M | 5.787 M | -4.955 M | -146.000 K | -5.296 M |